PMDD, a monthly mental health crisis

PMDD: When Your Cycle Becomes a Monthly Mental Health Crisis

By Leanne Mulheron

For most of the month, you are yourself. You are managing. You might even feel good.

And then, with a reliability that is almost clockwork, something shifts. In the one to two weeks before your period, you become someone you barely recognise. Rage that is out of proportion to what triggered it. A depression that arrives like a weather system and lifts almost the moment your period starts. Anxiety that spikes seemingly from nowhere. Thoughts that scare you.

If this is your experience, it is not ‘just PMS.’ It may be PMDD — Premenstrual Dysphoric Disorder — and it is a legitimate, diagnosable condition that is significantly underrecognised in Australia and globally.

What PMDD is — and what it isn’t

PMDD is a hormone-related mood disorder characterised by severe psychological and physical symptoms that occur in the luteal phase of the menstrual cycle (the roughly two weeks between ovulation and menstruation) and resolve shortly after menstruation begins. The key word is severe. PMDD is not a bad week. It is not being hormonal. It is a cyclical disorder that significantly impairs functioning and quality of life.

The distinction between PMS and PMDD is a matter of severity and functional impact. Premenstrual Syndrome (PMS) is common and relatively mild — bloating, mild mood changes, fatigue. PMDD involves symptoms that are debilitating: severe depression, suicidal ideation, explosive anger, intense anxiety, dissociation, and a feeling of being completely unlike yourself. Many women with PMDD describe the luteal phase as a recurring monthly crisis from which they know recovery is coming, but cannot feel it in the moment.

The cruelty of PMDD is that you know this will pass — and yet in the worst of it, you cannot reach that knowledge.

The neurobiology: it’s not about hormone levels

One of the most important things to understand about PMDD is that it is not caused by abnormal hormone levels. Women with PMDD do not have more oestrogen or progesterone than women without it. The distinguishing feature is an abnormal sensitivity to normal hormonal fluctuations — specifically, a disrupted response to the natural rise and fall of oestrogen and progesterone.

Research (I want to be careful here — this is an active area of investigation) suggests that this sensitivity involves the GABA system. GABA is the brain’s primary inhibitory neurotransmitter — it has a calming, regulatory function. Allopregnanolone, a metabolite of progesterone, normally enhances GABA’s calming effect. In women with PMDD, research indicates that this process appears to work paradoxically — the neurosteroid may trigger anxiety and mood disruption rather than calm. You may want to verify the current state of this research with a medical professional, as the evidence base is evolving.

This is important because it explains why common advice (‘track your cycle and plan around it,’ ‘eat less sugar,’ ‘exercise more’) often fails to adequately address PMDD. The mechanism is neurobiological and requires a neurobiological response — not simply better lifestyle management.

Symptoms: what PMDD looks like in the luteal phase

PMDD symptoms occur in a predictable luteal-phase window and resolve after menstruation. The clinical picture typically includes:

• Severe depression, hopelessness, or self-critical thoughts

• Suicidal ideation (this is not uncommon in PMDD and should always be taken seriously)

• Intense anxiety or panic that is qualitatively different from baseline

• Extreme irritability or rage — often disproportionate to the trigger, often frightening to the person experiencing it

• A profound sense of being overwhelmed by things that are normally manageable

• Social withdrawal and difficulty maintaining relationships during the luteal phase

• Cognitive symptoms: difficulty concentrating, poor memory, feeling mentally ‘slowed’

• Physical symptoms: bloating, breast tenderness, joint pain, fatigue

A defining feature of PMDD diagnosis is the symptom-free (or substantially symptom-reduced) window in the follicular phase (after menstruation and before ovulation). If your low periods do not have a clear cyclical pattern, or if symptoms persist throughout the whole cycle, a different diagnosis may be more accurate. Mood tracking across at least two cycles is typically recommended as part of assessment.

Why PMDD goes unrecognised — and the shame it creates

PMDD is frequently dismissed, minimised, or misdiagnosed. Women are told their symptoms are ‘just hormonal,’ as if that makes them less real. They are advised to track their mood (already doing that, thanks) or take vitamin B6. They are sometimes diagnosed with

depression or anxiety without the clinician identifying the cyclical pattern that would indicate PMDD.

The impact of this diagnostic delay is significant. Many women with PMDD spend years believing they are simply difficult, unstable, or fundamentally flawed — that the version of themselves in the luteal phase is somehow their ‘true self’ breaking through. This narrative is both inaccurate and deeply damaging.

There is also a particular shame that comes with PMDD when children, partners, or colleagues experience the emotional volatility of the luteal phase. Women often carry profound guilt for the rage, the withdrawal, the inconsistency — guilt that is compounded by a lack of any language for what is actually happening. ‘I don’t know what’s wrong with me’ is one of the most common sentences I hear from women who later turn out to have PMDD.

PMDD and perimenopause: a complicated intersection

For women approaching perimenopause, PMDD often intensifies. As cycles become more irregular and hormonal fluctuations become more pronounced, the luteal-phase dysregulation that defines PMDD can worsen significantly. Some women who managed PMDD adequately in their 30s find it becomes unmanageable in their early 40s.

There is also a subset of women for whom perimenopause — specifically the irregular, unpredictable hormonal swings of the transition — essentially creates PMDD-like symptoms that were not present before. This is sometimes referred to as perimenopausal mood disorder, and it operates through overlapping mechanisms.

The distinction matters clinically because the treatment approaches differ somewhat, and because misattributing perimenopausal mood symptoms to ‘just stress’ or ‘just anxiety’ delays appropriate support.

What actually helps

If you think you may have PMDD, the starting point is accurate assessment — ideally with a GP who takes cyclical mood disorders seriously, and a psychologist who can provide both diagnostic clarity and psychological support.

Evidence-informed approaches to PMDD management include (noting that treatment is individual and medical decisions should be made with a treating clinician):

• SSRIs taken either continuously or in the luteal phase only — one of the more consistently evidenced interventions for PMDD

• Hormonal interventions such as the combined oral contraceptive pill or, in some cases, hormonal therapies that suppress ovulation — discussed with a GP or gynaecologist

• Psychological approaches including CBT and mindfulness-based strategies — not as a primary treatment but as a complement to biological interventions

• Accurate psychoeducation — understanding what PMDD is, why it happens, and that it is not a character failing, is therapeutically significant in itself

What is worth noting clearly: PMDD is not a condition you should simply endure. It is treatable. Effective support exists. Getting to the right diagnosis is the critical first step.

Affinity Psychology provides assessment and psychological support for PMDD, cyclical mood disorders, and the intersection of hormones and mental health.

→ Appointments in Mona Vale and telehealth across Australia.

→ Book here